Subscriber access provided by Miami University Libraries
Article
Quantitative proteomics of TRAMP mice combined with bioinformatics analysis reveals that PDGF-B regulatory network plays a key role in prostate cancer progression Yuan Zhang, Dan Wang, Min Li, Xiaodan Wei, Shuang Liu, Miaoqing Zhao, Chu Liu, Xizhen Wang, Xingyue Jiang, Xuri Li, Shuping Zhang, Jonas Bergquist, Bin Wang, Chunhua Yang, Jia Mi, and Geng Tian J. Proteome Res., Just Accepted Manuscript • DOI: 10.1021/acs.jproteome.8b00158 • Publication Date (Web): 04 Jun 2018 Downloaded from http://pubs.acs.org on June 4, 2018
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 40 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of Proteome Research
Transgenic adenocarcinoma of the mouse prostate (TRAMP) mice is a widely used transgenic animal model of prostate cancer (PCa). We performed a label free quantitative proteomics analysis combined with a bioinformatics analysis on the entire prostate protein extraction from TRAMP mice and compared with WT littermates. From totally 2379 identified proteins, we presented a modest mice prostate reference proteome containing 919 proteins. 61 proteins presented a significant expression difference between two groups. The integrative bioinformatics analysis predicted the overexpression of platelet-derived growth factor B (PDGF-B) in tumor tissue and supports the hypothesis of the PDGF-B signaling network as a key upstream regulator in PCa progression. Furthermore, we demonstrated that Crenolanib, a novel PDGF receptor inhibitor, inhibited PCa cell proliferation in a dose-dependent manner. Finally, we revealed the importance of PDGF-B regulatory network in PCa progression, which will assist to understand the role and mechanisms of PDGF-B in promoting the cancer growth and provide valuable knowledge reference in the future research on anti-PDGF therapy. 529x211mm (300 x 300 DPI)
ACS Paragon Plus Environment
Journal of Proteome Research 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 2 of 40
1
Quantitative proteomics of TRAMP mice combined with bioinformatics analysis reveals
2
that PDGF-B regulatory network plays a key role in prostate cancer progression
3
Running title: Quantitative proteomics analysis of prostate cancer mice
4 5
Yuan Zhang1,#, Dan Wang1,2,#, Min Li1 , Xiaodan Wei1, Shuang Liu3, Miaoqing Zhao4, Chu Liu5,
6
Xizhen Wang6, Xingyue Jiang2, Xuri Li1, Shuping Zhang1, Jonas Bergquist1,7, Bin Wang1,
7
Chunhua Yang1,*, Jia Mi1,7,*, Geng Tian1,*
8 9 10 11 12 13 14 15 16 17 18 19 20 21
1. Medicine and Pharmacy Research Center, Binzhou Medical University, Laishan District,
No.346, Guanhai Road, Yantai, Shandong Province, 264003 China 2. Department of Radiology, Affiliated Hospital of Binzhou Medical University, 661 Second
Huanghe Rd, Binzhou, Shandong Province,256603 China 3. College of Enology, Binzhou Medical University, Laishan District, No.346,
Guanhai
Road, Yantai, Shandong Province, 264003 China 4. Department of Pathology, Provincial Hospital Affiliated to Shandong University, No. 324
Jingwu Weiqi Road, 250021, Jinan, Shandong Province, China. 5. Department
of Urology, Yantai Yuhuangding Hospital, Zhifu District, No.20,
Yuhuangding East Road, Yantai, Shandong Province, 264000 China 6. Imaging Center, Affiliated Hospital of Weifang Medical University, Kuiwen District,
NO.465, Yuhe Road, Weifang, Shandong Province, 256603 China 7. Department of Chemistry – BMC, Uppsala University, PO Box 599, Husargatan 3, 1
ACS Paragon Plus Environment
Page 3 of 40 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of Proteome Research
Uppsala, 75124
22
Sweden
23
#
24
*
25
Geng Tian; Phone: +86-535-6913395; Fax: +86-535-6913034
26
Email: Tiangeng@live.se
27
Or
28
Jia Mi; Phone: +86-535-6913395; Fax: +86-535-6913034
29
Email: jiajiami@gmail.com
30
Or
31
Chunhua Yang; Phone: +86-535-6913395; Fax: +86-535-6913034
32
Email: yangchunhua08@126.com
These authors have contributed equally to this work.
corresponding authors to
33 34
Word count: 5000
35
Figures: 5
36
Table:1
37
Supporting Information :11
38 39
2
ACS Paragon Plus Environment
Journal of Proteome Research 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
40
Abstract
41
Transgenic adenocarcinoma of the mouse prostate (TRAMP) mice is a widely used transgenic
42
animal model of prostate cancer (PCa). We performed a label free quantitative proteomics
43
analysis combined with a bioinformatics analysis on the entire prostate protein extraction from
44
TRAMP mice and compared with WT littermates. From totally 2379 identified proteins, we
45
presented a modest mice prostate reference proteome containing 919 proteins. 61 proteins
46
presented a significant expression difference between two groups. The integrative bioinformatics
47
analysis predicted the overexpression of platelet-derived growth factor B (PDGF-B) in tumor
48
tissues and supports the hypothesis of the PDGF-B signaling network as a key upstream
49
regulator in PCa progression. Furthermore, we demonstrated that Crenolanib, a novel PDGF
50
receptor inhibitor, inhibited PCa cell proliferation in a dose-dependent manner. Finally, we
51
revealed the importance of PDGF-B regulatory network in PCa progression, which will assist to
52
understand the role and mechanisms of PDGF-B in promoting the cancer growth and provide
53
valuable knowledge reference in the future research on anti-PDGF therapy.
54
Key words:
55
signal pathway
56
Introduction
57
Prostate cancer (PCa) remains the second most frequent cancer and the second cause of
58
cancer-related death in men1, 2. Although several effective therapy options are available, PCa is
59
still one of the most intriguing challenge in oncology due to the lack of knowledge of disease
60
progression mechanisms on the molecular and cellular levels3. Transgenic cancer animal models
PDGF-B; proteomics; prostate cancer; bioinformatics analysis; TRAMP mice;
3
ACS Paragon Plus Environment
Page 4 of 40
Page 5 of 40 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of Proteome Research
61
have provided a fundamental contribution to the investigation and understanding tumor growth,
62
and have been widely used in investigating multiple aspects of cancer progression.
63
The TRAMP model is one of the most well-known prostate cancer mouse models, which was
64
generated and characterized during 1995–19974, 5. All the male TRAMP mice develop prostatic
65
intraepithelial neoplasia (PIN) by 18 weeks of age, and display distant organ metastasis in lymph
66
nodes, adrenal glands, and the lungs. Two major advantages of the TRAMP mice are that 1) the
67
oncoprotein is specifically expressed in the prostate epithelial cells, and 2) the tumor tissue
68
resembles human prostate cancer histologically and biochemically4, 6, 7.
69
Several proteomics studies have already been conducted using the TRAMP mice. The effect of
70
methyl-Selenium compounds on TRAMP proteomic profiling was evaluated on a
71
MALDI-TOF/TOF MS platform with iTRAQ labeling8. Furthermore, the proteome difference of
72
dorsal-lateral (DLP) and ventral (VP) prostate was reported using the same platform9. For mouse
73
prostate proteome profiling, the most comprehensive study reported 619 distinct prostate proteins
74
from 1D-SDS gel coupled with LC-MS/MS identification10. However, a more comprehensive
75
and in-depth analysis of prostate proteome from TRAMP mice are still in need, and the
76
development of high resolution MS techniques has made this possible.
77
In the current study, we presented a comprehensive prostate gland proteomics comparison
78
between TRAMP mice and WT mice. A label free quantitative mass spectrometry-based analysis
79
was performed on prostate tissue proteins from TRAMP mice and WT mice. Using a
80
bioinformatics approach, we predicted the overexpression of PDGF-B in PCa tissues and
81
hypothesized a novel PDGF-B regulatory network. The overexpression of PDGF-B and 4
ACS Paragon Plus Environment
Journal of Proteome Research 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 6 of 40
82
associated regulatory network were experimentally validated in animal tissues and clinical
83
human samples. Furthermore, we reveal that inhibiting the PDGF signaling pathway using PDGF
84
receptor inhibitors can significantly inhibit prostate cancer cell growth both in vivo and in vitro.
85 86
Materials and Methods
87
Reagents
88
Anti-RAF-1 antibody (R&D Systems: MAB4540-SP), Anti-MAPK3 antibody (ZSGB-BIO;
89
sc-94), Anti-MAPK antibody (ZSGB-BIO; SC-7149), Anti-MAPK1 antibody (BIOSS;
90
bs-0022R), Anti-P85 antibody (BIOSS; bs-0128R), Anti-PRDX2 antibody (Abcam; ab109367),
91
Anti-PDIA3 antibody (Abcam; ab154197), Anti-GAPDH antibody (Santa Cruz; sc-32233), Anti-
92
HNRNPL antibody (Cell Signaling Technology; 4783), PDGF-BB (Prospec; cyt-501-b),
93
Anti-CD31 antibody (Cell Signaling Technology, 77699T),Anti-α-SMA antibody (CusAb,
94
CSB-MA080159), Anti-PCNA antibody (Abcam, EPR3821), Anti-Ki67 antibody (Proteintech,
95
27309-1-AP),
96
oligonucleotide
97
GCAAGCACCGGAAATTCAAGC; PGPU6/Neo-shNC: GTTCTCCGAACGTGTCACGT.
98
Mouse Strains TRAMP mice were purchased from Jackson Laboratory (www.jax.org). WT and
99
TRAMP mice were both from a C57BL/6 origin and obtained from C57- x C57-matings. The
100
genotype of animals was confirmed by PCR-based assay from tail biopsies DNA (Fig. S1A), and
101
the tumorigenesis was confirmed by high field (7T) small animal magnetic resonance imaging
The following reagents were used: Anti-PDGF-B antibody (Abcam; ab178409),
Crenolanib sequences
(Selleck
Chemicals
of
shRNAs
the
, used
CP-868596). are:
5
ACS Paragon Plus Environment
PDGF-B
and
PDGF-B-homo-1651
control shRNA:
Page 7 of 40 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of Proteome Research
102
(MRI) (Bruker BioSpin, Germany) (Fig. S1B). The detailed method was described previously5, 11.
103
The PCR primers were listed in Supplement materials (Supplemental Table S1).
104
Tissue Collection Both WT mice and TRAMP mice were sacrificed at the age of 18 weeks. The
105
entire prostate gland was isolated from WT mice. In TRAMP mice, the entire prostate gland
106
together with associated cancer tissue were collected. The samples were rinsed with PBS buffer
107
and snap frozen in liquid nitrogen and stored at -80°C for further analysis. Four pairs of prostate
108
cancer and adjacent normal prostate tissues were obtained from patients undergoing radical
109
prostatectomy in Yuhuangding Hospital, Yantai, China.
110
Protein Extraction Prostate tissue samples from TRAMP and WT mice were suspended and
111
homogenized in lysis buffer (9 M Urea, 20mM HEPES, and proteinase inhibitor)). Samples were
112
sonicated shortly followed by centrifugation at 12,000 g at 4 °C for 10 min. The lysates were
113
stored at −80 °C.
114
In-solution Digestion and Peptide Purification In-solution digestion was performed prior to the
115
MS analysis. 35µg proteins were diluted in 100µL digestion buffer (6 M urea, 100mM TEAB).
116
Then 10µL of 45mM DTT solution was added and incubated at 50°C for 15min, followed by the
117
addition of 10µL 100mM IAA solution and incubated in darkness at room temperature for 15
118
min. Trypsin/Lys-C (Wako Chemicals, Osaka, Japan) was dissolved in digestion buffer and
119
added in each sample to reach a final trypsin/protein concentration of 5% (w/w) and followed by
120
incubation overnight at 37°C. The digestion was stopped by diluting the sample 1:1 with
121
trifluoroacetic acid (TFA) in acetonitrile (ACN) and MilliQ water (1/5/94, v/v). A sample 6
ACS Paragon Plus Environment
Journal of Proteome Research 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 8 of 40
122
corresponding to 20µg digested proteins was desalted using C18 Stage-tips with
123
EmporeDisksC18 from Varian (Palo Alto, CA, USA), and dried completely in a vacuum
124
centrifuge.
125
Mass Spectrometry all analyses were performed using a QExactive plus Orbitrap mass
126
spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a nano electrospray
127
ion source as described. Dried Samples were dissolved with 0.1% formic acid. Peptides were
128
separated by reversed phase liquid chromatography using an EASY-nLC 1000 system (Thermo
129
Fisher Scientific, Bremen, Germany). A set-up of a two-step column separation was used. The
130
pre-column was a 2 cm EASY-column (1D 100 µm, 5 µm, C18) (Thermo Fisher Scientific),
131
while the analytical column was a 10 cm EASY-column (1D 75 µm, 3 µm, C18) (Thermo Fisher
132
Scientific). Peptides were eluted with a 90-min long linear gradient from 4% to 100% ACN at
133
250nl/min. The mass spectrometer was operated in positive ion mode acquiring a survey mass
134
spectrum with resolving power 70 000 and consecutive high collision dissociation (HCD)
135
fragmentation spectra of the 10 most abundant ions.
136
Data Analysis Acquired data (RAW-files) were processed by MaxQuant (version 1.4.0.1).
137
Tandem mass spectra were searched with Andromeda against the UniProt mouse database
138
(release 2015–05, with 76089 protein entries). The searching settings were set as:
139
ppm and 5 ppm error tolerance for the survey scan and MS/MS analysis respectively; enzyme
140
specificity was trypsin/Lys-C; maximum two missed cleavage sites allowed; cysteine
141
carbamidomethylation was set as static modification; Oxidation (M) was set as dynamic
142
modification. A maximum false discovery rate (FDR) of 1% for peptides and proteins was 7
ACS Paragon Plus Environment
maximum 10
Page 9 of 40 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of Proteome Research
143
selected. The protein identifications were based on at least two matched peptides. Feature
144
matching between raw files was enabled, using a retention time window of 2 min. Both razor and
145
unique peptides were used for Label free quantification (LFQ). A decoy sequence database was
146
constructed by reversing the target sequence database. A list of known contamination was also
147
included in the identification. Averaged LFQ intensity values were used to for further data
148
analysis. The mass spectrometry proteomics data have been deposited to the ProteomeXchange
149
Consortium12
150
PXD003749(http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD003749).
151
Username: reviewer67745@ebi.ac.uk
152
Password: QaWULAUh
153
Pathway Analysis and Network Analysis The Pathway analysis was performed through the use
154
of
155
www.qiagen.com/ingenuity). Differential expressed proteins were uploaded to IPA 2015 winter
156
release. A core analysis was performed including canonical pathway analysis, upstream regulator
157
analysis, casual network analysis, and network analysis.
158
Immunoblot Collected cells and tissues were suspended in lysis buffer (50mM Tris, pH 7.4,
159
100mM NaCl2, 1mM MgCl2, 2.5mM Na3VO4,1mM PMSF, 2.5mM EDTA, 0.5% Triton X-100,
160
0.5% NP-40, and proteinase inhibitor). The lysates were centrifuged at 12,000 g for 10 min at
161
4°C. 20 µg of proteins was used for immunoblot analysis. All the analyses were replicated for at
162
least three times and representative blots are presented.
163
Immunohistochemistry Formalin-fixed, paraffin-embedded prostate cancer tissues were used for
QIAGEN’s
via
the
PRIDE
Ingenuity
partner
Pathway
repository
Analysis
(IPA®,
8
ACS Paragon Plus Environment
with
the
QIAGEN
dataset
identifier
Redwood
City,
Journal of Proteome Research 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
164
selected proteins immunohistochemical staining. After deparaffinage and blocking, the
165
antigen–antibody reaction was incubated overnight at 4°C. Diaminobenzidine (DAB) reagents
166
were applied to detect the signal from the antigen-antibody reaction. All sections were
167
counterstained with hema-toxylin. IHC was scored independently using software Image Pro-plus.
168
RNA Isolation and Quantitative Real-Time PCR Total RNA were extracted with the TRIzol
169
reagent kit (Invitrogen, Carlsbad, CA, USA). Reverse transcription was performed using
170
M-MLV reverse transcriptase cDNA Synthesis Kit (Takara Bio, Otsu, Shiga, Japan). qRT-PCR
171
was carried out on an ABI 7900HT Fast Real-Time PCR System (Foster City, CA, USA) with
172
SYBR-Green PCR Master Mix (Toyobo, Kita-ku, Osaka , Japan).
173
Human Prostate Cancer Cell Lines Human LNCaP cell line was obtained from China
174
Infrastructure of Cell Line Resource. Cells were grown in RPMI-1640 medium supplemented
175
with 10% FBS. All cells were maintained at 37°C in 5% CO2 until treatment. Routine
176
mycoplasma testing was performed regularly.
177
Cell Culture and Transfection Approximately 4x105 cells were seeded on 6-well plates for
178
qRT-PCR and Western Blot validation. The cells were cultured until reaching 50–60%
179
confluence prior to transfection. Transfection was performed with 2µg shRNA-PDGF-B
180
plasmids and 1-2µl LipofectamineTM 2000 in 200µL OptiMEM®-I per well for 3 hours. For cell
181
proliferation assay, 5x103 cells were seeded on 96-well plates. 0.2µg shRNA-PDGF-B plasmids
182
and 0.1-0.2µl LipofectamineTM 2000 in 200µL OptiMEM®-I per well were added to plate and
183
incubated for 3 hours. The transfected cells were cultured in RPMI 1640 medium supplemented
184
with 10% FBS for 48 or 72 hours before analysis. 9
ACS Paragon Plus Environment
Page 10 of 40
Page 11 of 40 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of Proteome Research
185
Cell Proliferation Assay 5 mg/mL MTT in PBS was added to each well to a final concentration
186
of 0.5 mg/mL. The mixture was incubated for 4 hour at 37°C. The supernatant was removed and
187
150µL DMSO was added. The absorbance was measured at the wavelength of 450nm. All
188
experiments were performed in triplicates for each treatment.
189
In vivo Animal model treatment TRAMP and WT mice at 10 weeks age were randomized into
190
control and treated cohort and treated i.p. either with normal saline (NaCl 0.9%) , or Crenolanib
191
15 mg/kg twice daily (n=6 per group). All the animals were sacrificed after follow-up of 56 days.
192
The prostate glands were collected and fixed. Microvessel density of tumor was analyzed by
193
anti-CD31 and anti α-SMA immunostaining for assessing the compound effects. Cell
194
proliferation was analyzed by anti-Ki67 and anti-PCNA immunostaining
195
Statistics — Data were presented as mean ± SE, and analyzed with the two-tailed Student’s t-test
196
between two groups. It was considered statistically significant if the P-value was lower than 0.05.
197
Principle component analysis (PCA) was performed using the Excel add-in Multibase package
198
(Numerical Dynamics, Japan). RNA binding sites were predicted with web server RBPmap
199
(http://rbpmap.technion.ac.il/index.html)13.
200 201
Results
202
Reference Map of the Mouse prostate Proteome
203
In this study, we extended the coverage of the mouse prostate proteome with state-of-the-art
204
proteomics and performed an in-depth analysis of proteins present in the entire mouse prostate 10
ACS Paragon Plus Environment
Journal of Proteome Research 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
205
gland (Fig 1A). In total, 2379 non-redundant proteins were identified across eight individual
206
animals after removal of known contaminates and proteins found from the decoy database. For
207
higher confidence, only proteins with identification in at least two individual animals were
208
included in the reference proteome (Table S2). The Gene Ontology analysis of reference proteins
209
indicated that prostate proteins are mostly involved in catalytic activities (40.7%). The detailed
210
protein distribution presented as molecular function, cellular component content, biological
211
process and protein class is found in Fig. S2. In TRAMP mice, 1086 proteins were identified in
212
at least two TRAMP mice. The overlap of proteins can be seen in Fig. 1B. For the subsequent
213
bioinformatics analysis, we focused on 11 proteins that were quantitated in all four biological
214
replicates in TRAMP mice but never identified in WT mice, as well as one protein was identified
215
in all four biological replicates in WT mice but never identified in TRAMP mice (Table 1a and
216
1b).
217
218
219
220
221 222 11
ACS Paragon Plus Environment
Page 12 of 40
Page 13 of 40 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Journal of Proteome Research
223 224 225 226 227 228 229 230 231 232
Figure 1. Differential proteomics analysis of TRAMP and WT mice. A. Workflow for the analysis of TRAMP and WT mouse proteomes. B. Venn diagram showing the overlap between the proteins identified in TRAMP mice and WT mice. C. Volcano plot illustrating significantly differential abundant proteins in quantitative analysis. The -log10 (Pvalue) is plotted against the log2(Ratio TRAMP/WT). The red dots indicate proteins with significantly different expression between TRAMP and WT mice, the black dots indicate proteins not significantly different in the TRAMP and WT mice. D. Principal component analysis of quantitative proteome profiles of TRAMP and WT mice. The first and second principal components of each analysis were calculated and plotted. The relative distance between points is a measure of similarity or difference. The clustering shows clear differentiation of animal groups. E. PDGFB regulatory network was predicted based on experimental evidences in IPA knowledgebase. The key of figure legend is shown at right side.
233 234 235
Table 1a. List of 11 proteins that uniquely identified in TRAMP mice prostate IDs
Symbol
Full names
Q9EPV7 Q99KR7 G5E8K5-2 Q9DBE0 Q62318 Q922B1 A2ADY9 P62965 P50544 E9PWU4 Q62446
9530002B09Rik Ppif Ank3 Csad Trim28 Macrod1 Ddi2 Crabp1 Acadvl Adipoq Fkbp3
AUMP Peptidyl-prolyl cis-trans isomerase F, mitochondrial Ankyrin-3 Cysteine sulfinic acid decarboxylase Transcription intermediary factor 1-beta O-acetyl-ADP-ribose deacetylase MACROD1 Protein DDI1 homolog 2 Cellular retinoic acid-binding protein 1 Very long-chain specific acyl-CoA dehydrogenase, mitochondrial Adiponectin Peptidyl-prolyl cis-trans isomerase FKBP3
236
Table 1b. List of 1 proteins that uniquely identified in WT mice prostate
237 IDs
Symbol
Full names
Q9JLV1
Bag3
BAG family molecular chaperone regulator 3
238
239 240 241 242 243 12
ACS Paragon Plus Environment
Journal of Proteome Research 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
244
Quantitative proteomics analysis of the entire prostate glands from WT and TRAMP mice
245
In the quantitative proteomics analysis, we focused on 515 proteins that were identified in all 8
246
individual animals. Biostatistics analysis reveals 61 proteins presented significantly between WT
247
and TRAMP group (p